Correcting for the influence of sampling conditions on biomarkers of exposure to phenols and phthalates: a 2-step standardization method based on regression residuals

Marion Mortamais, Cécile Chevrier, Claire Philippat, Claire Petit, Antonia M Calafat, Xiaoyun Ye, Manori J Silva, Christian Brambilla, Marinus J C Eijkemans, Marie-Aline Charles, Sylvaine Cordier, Rémy Slama, Marion Mortamais, Cécile Chevrier, Claire Philippat, Claire Petit, Antonia M Calafat, Xiaoyun Ye, Manori J Silva, Christian Brambilla, Marinus J C Eijkemans, Marie-Aline Charles, Sylvaine Cordier, Rémy Slama

Abstract

Background: Environmental epidemiology and biomonitoring studies typically rely on biological samples to assay the concentration of non-persistent exposure biomarkers. Between-participant variations in sampling conditions of these biological samples constitute a potential source of exposure misclassification. Few studies attempted to correct biomarker levels for this error. We aimed to assess the influence of sampling conditions on concentrations of urinary biomarkers of select phenols and phthalates, two widely-produced families of chemicals, and to standardize biomarker concentrations on sampling conditions.

Methods: Urine samples were collected between 2002 and 2006 among 287 pregnant women from Eden and Pélagie cohorts, from which phthalates and phenols metabolites levels were assayed. We applied a 2-step standardization method based on regression residuals. First, the influence of sampling conditions (including sampling hour, duration of storage before freezing) and of creatinine levels on biomarker concentrations were characterized using adjusted linear regression models. In the second step, the model estimates were used to remove the variability in biomarker concentrations due to sampling conditions and to standardize concentrations as if all samples had been collected under the same conditions (e.g., same hour of urine collection).

Results: Sampling hour was associated with concentrations of several exposure biomarkers. After standardization for sampling conditions, median concentrations differed by--38% for 2,5-dichlorophenol to +80 % for a metabolite of diisodecyl phthalate. However, at the individual level, standardized biomarker levels were strongly correlated (correlation coefficients above 0.80) with unstandardized measures.

Conclusions: Sampling conditions, such as sampling hour, should be systematically collected in biomarker-based studies, in particular when the biomarker half-life is short. The 2-step standardization method based on regression residuals that we proposed in order to limit the impact of heterogeneity in sampling conditions could be further tested in studies describing levels of biomarkers or their influence on health.

Figures

Figure 1
Figure 1
Flow Chart of Study Population, Composed of Pregnant Women from Eden and Pélagie Cohorts, France, 2002 – 2006.

References

    1. Pereira C, Mapuskar K, Vaman Rao C. A two-generation chronic mixture toxicity study of Clophen A60 and diethyl phthalate on histology of adrenal cortex and thyroid of rats. Acta Histochem. 2007;109(1):29–36. doi: 10.1016/j.acthis.2006.09.008.
    1. vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, Farabollini F, Guillette LJ, Hauser R, Heindel JJ. et al.Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol. 2007;24(2):131–138. doi: 10.1016/j.reprotox.2007.07.005.
    1. Adibi JJ, Perera FP, Jedrychowski W, Camann DE, Barr D, Jacek R, Whyatt RM. Prenatal exposures to phthalates among women in New York City and Krakow, Poland. Environ Health Perspect. 2003;111(14):1719–1722. doi: 10.1289/ehp.6235.
    1. Ye X, Pierik FH, Angerer J, Meltzer HM, Jaddoe VW, Tiemeier H, Hoppin JA, Longnecker MP. Levels of metabolites of organophosphate pesticides, phthalates, and bisphenol A in pooled urine specimens from pregnant women participating in the Norwegian Mother and Child Cohort Study (MoBa) Int J Hyg Environ Health. 2009;212(5):481–491. doi: 10.1016/j.ijheh.2009.03.004.
    1. Ye X, Pierik FH, Hauser R, Duty S, Angerer J, Park MM, Burdorf A, Hofman A, Jaddoe VW, Mackenbach JP. et al.Urinary metabolite concentrations of organophosphorous pesticides, bisphenol A, and phthalates among pregnant women in Rotterdam, the Netherlands: the Generation R study. Environ Res. 2008;108(2):260–267. doi: 10.1016/j.envres.2008.07.014.
    1. Engel SM, Miodovnik A, Canfield RL, Zhu C, Silva MJ, Calafat AM, Wolff MS. Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect. pp. 565–571.
    1. Foster PM. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl. 2006;29(1):140–147. doi: 10.1111/j.1365-2605.2005.00563.x. discussion 181–145.
    1. Hogberg J, Hanberg A, Berglund M, Skerfving S, Remberger M, Calafat AM, Filipsson AF, Jansson B, Johansson N, Appelgren M. et al.Phthalate diesters and their metabolites in human breast milk, blood or serum, and urine as biomarkers of exposure in vulnerable populations. Environ Health Perspect. 2008;116(3):334–339.
    1. Ye X, Kuklenyik Z, Needham LL, Calafat AM. Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2005;383(4):638–644. doi: 10.1007/s00216-005-0019-4.
    1. Koch HM, Bolt HM, Angerer J. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP. Arch Toxicol. 2004;78(3):123–130. doi: 10.1007/s00204-003-0522-3.
    1. Volkel W, Colnot T, Csanady GA, Filser JG, Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol. 2002;15(10):1281–1287. doi: 10.1021/tx025548t.
    1. Hoppin JA, Brock JW, Davis BJ, Baird DD. Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ Health Perspect. 2002;110(5):515–518. doi: 10.1289/ehp.02110515.
    1. Adibi JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, Herrick R, Nelson H, Bhat HK, Perera FP, Silva MJ. et al.Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect. 2008;116(4):467–473.
    1. Preau JL, Wong LY, Silva MJ, Needham LL, Calafat AM. Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ Health Perspect. 2010;118(12):1748–1754. doi: 10.1289/ehp.1002231.
    1. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, Needham LL, Calafat AM. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999 – 2000. Environ Health Perspect. 2004;112(3):331–338.
    1. Ye X, Wong LY, Bishop AM, Calafat AM. Variability of Urinary Concentrations of Bisphenol A in Spot Samples, First-morning Voids, and 24-Hour Collections. Environ Health Perspect. 2011.
    1. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Urinary concentrations of triclosan in the U.S. population: 2003 – 2004. Environ Health Perspect. 2008;116(3):303–307.
    1. Tworoger SS, Hankinson SE. Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control. 2006;17(7):889–899. doi: 10.1007/s10552-006-0035-5.
    1. Wang Y, Jacobs EJ, McCullough ML, Rodriguez C, Thun MJ, Calle EE, Flanders WD. Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d. Am J Epidemiol. 2009;170(1):88–94. doi: 10.1093/aje/kwp086.
    1. Drouillet P, Kaminski M, De Lauzon-Guillain B, Forhan A, Goua V, Thiébaugeorges O, Schweitzer M, Magnin G, Ducimetière P, Charles MA. Association between maternal fish and shells consumption before pregnancy and fetal growth: evidence for an association in overweight women. The “EDEN mother-child” cohort (study of pre and early postnatal determinants of the child’s development and health) Paediatric and perinatal epidemiology. 2008. pp. 1–9.
    1. Slama R, Thiebaugeorges O, Goua V, Aussel L, Sacco P, Bohet A, Forhan A, Ducot B, Annesi-Maesano I, Heinrich J. et al.Maternal personal exposure to airborne benzene and intrauterine growth. Environ Health Perspect. 2009;117(8):1313–1321.
    1. Guldner L, Monfort C, Rouget F, Garlantezec R, Cordier S. Maternal fish and shellfish intake and pregnancy outcomes: a prospective cohort study in Brittany, France. Environ Health. 2007;6:33. doi: 10.1186/1476-069X-6-33.
    1. Garlantezec R, Monfort C, Rouget F, Cordier S. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population. Occup Environ Med. 2009;66(7):456–463. doi: 10.1136/oem.2008.041772.
    1. Philippat C, Mortamais M, Chevrier C, Petit C, Calafat AM, Ye X, Silva MJ, Brambilla C, Pin I, Charles MA. et al.Exposure to Phthalates and Phenols during Pregnancy and Offspring Size at Birth. Environ Health Perspect. 2012;120(3):464–470.
    1. Chevrier C, Petit C, Philippat C, Mortamais M, Slama R, Rouget F, Calafat AM, Ye X, Silva MJ, Charles MA. et al.Maternal Urinary Phthalates and Phenols and Male Genital Anomalies. Epidemiology. 2012;23(2):353–356. doi: 10.1097/EDE.0b013e318246073e.
    1. Silva MJ, Samandar E, Preau JL Jr. Reidy JA, Needham LL, Calafat AM: Quantification of 22 phthalate metabolites in human urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;860(1):106–112. doi: 10.1016/j.jchromb.2007.10.023.
    1. Center for Diseases Controls and Prevention. Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables.
    1. Hornung RW, Reed LD. Estimation of average concentration in the presence of non-detectable values. Appl Occup Environ Hyg. 1990;5:46–51. doi: 10.1080/1047322X.1990.10389587.
    1. Richardson DB, Rzehak P, Klenk J, Weiland SK. Analyses of case – control data for additional outcomes. Epidemiology. 2007;18(4):441–445. doi: 10.1097/EDE.0b013e318060d25c.
    1. Hauser R, Meeker JD, Park S, Silva MJ, Calafat AM. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect. 2004;112(17):1734–1740. doi: 10.1289/ehp.7212.
    1. Teeguarden JG, Calafat AM, Ye X, Doerge DR, Churchwell MI, Gunawan R, Graham MK. Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol Sci. 2011;123(1):48–57. doi: 10.1093/toxsci/kfr160.
    1. Samandar E, Silva MJ, Reidy JA, Needham LL, Calafat AM. Temporal stability of eight phthalate metabolites and their glucuronide conjugates in human urine. Environ Res. 2009;109(5):641–646. doi: 10.1016/j.envres.2009.02.004.
    1. Wolff MS, Engel SM, Berkowitz GS, Ye X, Silva MJ, Zhu C, Wetmur J, Calafat AM. Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect. 2008;116(8):1092–1097. doi: 10.1289/ehp.11007.
    1. Casas L, Fernandez MF, Llop S, Guxens M, Ballester F, Olea N, Irurzun MB, Rodriguez LS, Riano I, Tardon A. et al.Urinary concentrations of phthalates and phenols in a population of Spanish pregnant women and children. Environ Int. 2011;37(5):858–866. doi: 10.1016/j.envint.2011.02.012.
    1. Commission directive 2004/93/EC of 21 september 2004 amending council directive 76/768/EEC for the purpose of adapting its annexes II and III to technical progress.
    1. Braun JM, Kalkbrenner AE, Calafat AM, Bernert JT, Ye X, Silva MJ, Barr DB, Sathyanarayana S, Lanphear BP. Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ Health Perspect. 2011;119(1):131–137.
    1. Schisterman EF, Vexler A, Whitcomb BW, Liu A. The limitations due to exposure detection limits for regression models. Am J Epidemiol. 2006;163(4):374–383.
    1. Fewell Z, Davey Smith G, Sterne JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007;166(6):646–655. doi: 10.1093/aje/kwm165.
    1. Buonaccorsi JP, editor. Measurement error: models, methods, and applications. Boca Raton: CRC Press; 2010.
    1. Fisher JW, Twaddle NC, Vanlandingham M, Doerge DR. Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans. Toxicol Appl Pharmacol. 2011;257(1):122–136. doi: 10.1016/j.taap.2011.08.026.
    1. Lorber M, Angerer J, Koch HM. A simple pharmacokinetic model to characterize exposure of Americans to di-2-ethylhexyl phthalate. J Expo Sci Environ Epidemiol. 2010;20(1):38–53. doi: 10.1038/jes.2008.74.
    1. Dempsey D, Jacob P, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002;301(2):594–598. doi: 10.1124/jpet.301.2.594.
    1. Preis SR, Spiegelman D, Zhao BB, Moshfegh A, Baer DJ, Willett WC. Application of a repeat-measure biomarker measurement error model to 2 validation studies: examination of the effect of within-person variation in biomarker measurements. Am J Epidemiol. 2011;173(6):683–694. doi: 10.1093/aje/kwq415.
    1. Armstrong B. In: Exposure Assessment in occupational and Environmental Epidemiology. Nieuwenhuijsen MJ, editor. Oxford University Press; 2003. Exposure measurement error: consequences and design issues.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir